MTCR Insider Trading
Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 13.80%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00
Metacrine Insider Trading History Chart
This chart shows the insider buying and selling history at Metacrine by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
Metacrine Share Price & Price History
Current Price: $0.58
Price Change: +0.30 (1.20%)
As of 06/20/2023 01:00 AM ET
Metacrine Insider Trading History
Metacrine Institutional Trading History
Data available starting January 2016
Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases. It is developing MET642, which has completed Phase I clinical trial for the treatment of ulcerative colitis. Metacrine, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Read More on Metacrine
Volume
83,889 shs
Average Volume
225,834 shs
Market Capitalization
$24.75 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A